Semaglutide Injection
From $149/month
The most widely studied GLP-1 medication. A once-weekly subcutaneous injection of compounded semaglutide, the same GLP-1 molecule studied in today’s leading weight-loss research.
No insurance required
Licensed US pharmacies
Fast, discreet shipping
1–2 lbs per week on average in trials of the branded medicine, individual results vary
One simple weekly injection, self-administered at home
Personalized, titrated dosing from your physician
Get Started
Available only if prescribed by a licensed provider after an online consultation.
Why semaglutide
Semaglutide is a GLP-1 receptor agonist characterized in receptor assays.
Vehicle
Semaglutide (assay)
GLP-1 receptor cAMP activation.
In recombinant GLP-1 receptor cell systems, semaglutide produces concentration-dependent cAMP accumulation. The schematic dose–response below reflects the shape of published in vitro agonism curves used to report potency (EC50), not clinical weight or glycemic outcomes.
Source: Lau et al., “Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide,” Journal of Medicinal Chemistry (2015).
Educational research summary only. Schematics illustrate published pharmacology / pharmaceutics concepts and are not clinical results, performance claims, or medical advice.
Related treatments
Ready to get started?
Begin your free online intake. A licensed provider reviews every order, and treatment ships only if prescribed.